Mark Sheptoff Financial Planning, LLC Ani Pharmaceuticals Inc Transaction History

Mark Sheptoff Financial Planning, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$55.65 - $79.83 $191,992 - $275,413	-3,450 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$64.7 - $85.39 $19,410 - $25,617	-300 Reduced 8.0%	3,450 $251,000
Q4 2018 Feb 11, 2019	SELL	$41.17 - $56.44 $12,351 - $16,932	-300 Reduced 7.41%	3,750 $169,000
Q4 2017 Feb 09, 2018	SELL	$53.3 - $74.56 $63,960 - $89,472	-1,200 Reduced 22.86%	4,050 $261,000
Q3 2017 Nov 09, 2017	BUY	$43.46 - $52.49 $228,165 - $275,572	5,250	5,250 $276,000

215

19.1M

3.4K

10.8K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.18B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Mark Sheptoff Financial Planning, LLC, based on Form 13F filings with the SEC.

Stay updated on Mark Sheptoff Financial Planning, LLC with notifications on news.